archTIS FY2026 Closes with Record Sales and Strong Momentum
Key points
- Annual Recurring Revenue (ARR) of $14.8M, up 209% YoY
- Q4 revenue of $3.5M, up 92% YoY
- U.S. Department of Defense completed final testing of NC Protect
- Australian Department of Defence awarded a $3.2M contract
Full summary
archTIS Limited closed FY2026 with record contracted sales of $14.1M, a 65% increase from FY25. The quarter saw a significant increase in Annual Recurring Revenue (ARR) to $14.8M, up 209% from the prior year, with Q4 revenue at $3.5M, up 92% year-on-year. The company's gross margin remained strong at 74% for both Q4FY26 and FY26. Operating expenses decreased by 11% quarter-on-quarter, reflecting ongoing cost management efforts. The U.S. Department of Defense completed final production testing of NC Protect, passing all test cases, and enterprise licensing negotiations advanced. The Australian Department of Defence awarded archTIS a $3.2M contract, renewing and expanding its Kojensi commitment.
Summary generated by a large language model. Please interpret with care.